Advisory Services Network’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Advisory Services Network’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-90	Closed	-$1K	–	3606
2021 Q2	$1K	Buy	+90	New	+$638	﹤0.01%	3568
2021 Q1	–	Sell	-90	Closed	-$1K	–	3259
2020 Q4	$1K	Sell	90 -500	-85%	-$4.1K	﹤0.01%	3242
2020 Q3	$7K	Buy	+590	New	+$4.09K	﹤0.01%	2668

Other funds holding KLDO

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Advisory Services Network's KLDO Position: Q3 2021 in Review

Advisory Services Network sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q3 2021, closing a stake of 90 shares — an estimated $1K sold.

Advisory Services Network first reported a position in KLDO in Q3 2020 and held it in 3 quarters. The position peaked at $7K in Q3 2020. 71 funds tracked by Wall St. Rank hold KLDO as of Q3 2021.

Advisory Services Network reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Advisory Services Network sold 90 Kaleido Biosciences, Inc. Common Stock shares in Q3 2021, an estimated $1K.
Advisory Services Network first reported a position in Kaleido Biosciences, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
Advisory Services Network's Kaleido Biosciences, Inc. Common Stock position peaked at $7K in Q3 2020.
71 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.